Merck Foundation STEM Program

Merck Foundation STEM Program is sponsored by Merck Foundation. The Merck Foundation STEM Program partners with global and local institutions and organizations to empower women and young people in the areas of science and technology, believing that education is an important factor in promoting economic well-being in Africa.

Merck Foundation - Merck. com The Merck Foundation is dedicated to advancing access to health by supporting innovative programs and partnerships to improve the health and well-being of people around the world.

Our new initiative, Community Collaborative for Reimagining HIV Care, aims to improve timely access to and continuity of high-quality care for people living with HIV in under-resourced communities across the U.S. To be considered for participation in this initiative, the call for proposals is now open.

Learn more, including how to submit a proposal Helping build stronger health systems and address barriers to high-quality care Through our programs, we believe that by working closely with governments, donors, patient groups, healthcare professionals, nonprofit organizations, academic institutions, multilateral agencies, the private sector and others, we can help build stronger health systems that provide better care.

The Merck Foundation is a private, charitable organization established and funded by Merck. It’s a separate legal entity from Merck and operates independently. Our company established the Merck Foundation (the “Foundation”) in 1957.

The Foundation has contributed more than $1 billion to support initiatives that address important global health and societal needs. It’s our chief source of financial support for eligible nonprofit organizations and innovative programs that align with our two focus areas: health and community.

Our commitment to advancing access to health We invest in philanthropic programs that aim to improve the quality of healthcare and address barriers to accessing care for people living with cancer, cardiovascular disease, diabetes and HIV/AIDS. Supporting community grants Through our community grants programs, we’re working to enhance the health and well-being of the communities where our employees live and work.

Improving healthcare access We find sustainable ways to enable access to healthcare for people living in underserved communities around the world. Strengthening our communities Our programs aim to build stronger communities by helping address critical health and social needs. Global emergency response We’re committed to supporting communities around the world that are affected by natural disasters and humanitarian crises.

Forward-Looking Statement of Merck & Co. , Inc., Rahway, N. J.

, USA This website of Merck & Co. , Inc., Rahway, N. J.

, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties.

There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site ( www. sec. gov ).

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.